Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Int Arch Allergy Immunol ; 155 Suppl 1: 40-5, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21646794

RESUMEN

BACKGROUND: Eosinophilic gastrointestinal disorders (EGIDs) are disorders characterized by primary eosinophil inflammation in the gastrointestinal tract. There are a small number of reports of eosinophil infiltration in gastrointestinal tracts presenting as EGIDs in infants. In this study, we present Japanese cases of EGIDs in infants. METHODS: Five patients diagnosed with or strongly suspected to have EGIDs in our hospital from 2008 to 2010 were reviewed. Radiographic contrast enema examinations and/or endoscopies were performed in 4 and 3 patients, respectively. RESULTS: There were patients with eosinophilic colitis (1 suspected and 2 biopsy-proven), a patient who was suspected of having allergic eosinophilic enterocolitis, and a patient with eosinophilic gastroenteritis associated with pediatric hypereosinophilic syndrome. CONCLUSIONS: The causes and clinical findings of patients with intestinal eosinophil inflammation vary. Therefore, deliberate examination and observation are important for patients with infantile EGID.


Asunto(s)
Enteritis , Eosinofilia , Gastritis , Colon/patología , Anomalías Congénitas/patología , Constricción Patológica/patología , Eccema/complicaciones , Enteritis/sangre , Enteritis/complicaciones , Enteritis/diagnóstico , Enteritis/etiología , Enteritis/patología , Enteritis/terapia , Eosinofilia/sangre , Eosinofilia/complicaciones , Eosinofilia/diagnóstico , Eosinofilia/etiología , Eosinofilia/patología , Eosinofilia/terapia , Eosinófilos/patología , Heces/citología , Femenino , Mucosa Gástrica/patología , Gastritis/sangre , Gastritis/complicaciones , Gastritis/diagnóstico , Gastritis/etiología , Gastritis/patología , Gastritis/terapia , Humanos , Síndrome Hipereosinofílico/sangre , Síndrome Hipereosinofílico/complicaciones , Síndrome Hipereosinofílico/patología , Inmunoglobulina E/sangre , Inmunoglobulina E/inmunología , Lactante , Recién Nacido , Mucosa Intestinal/patología , Japón , Masculino , Hipersensibilidad a la Leche/complicaciones , Hipersensibilidad a la Leche/inmunología , Miocarditis/complicaciones , Sangre Oculta , Prednisolona/uso terapéutico , Recto/patología , Síndrome
2.
J Biol Chem ; 283(39): 26820-8, 2008 Sep 26.
Artículo en Inglés | MEDLINE | ID: mdl-18667423

RESUMEN

OTT/RBM15-BSAC/MAL/MKL1/MRTF-A was identified as a fusion transcript generated by t(1;22)(p13;q13) in acute megakaryoblastic leukemia. Previous studies have shown that BSAC (basic, SAP, and coiled-coil domain) activates the promoters containing CArG boxes via interaction with serum response factor, and OTT (one twenty-two) negatively regulates the development of megakaryocytes and myeloid cells. However, the mechanism by which OTT-BSAC promotes leukemia is largely unknown. Here we show that OTT-BSAC, but not BSAC or OTT strongly activates several promoters containing a transcription factor Yin Yang 1-binding sequence. In addition, although BSAC predominantly localizes in the cytoplasm and its nuclear translocation is considered to be regulated by the Rho-actin signaling pathway, OTT-BSAC exclusively localizes in the nucleus. Moreover, OTT interacts with histone deacetylase 3, but this interaction is abolished in OTT-BSAC. Collectively, these functional and spatial changes of OTT and BSAC caused by the fusion might perturb their functions, culminating in the development of acute megakaryoblastic leukemia.


Asunto(s)
Núcleo Celular/metabolismo , Proteínas de Unión al ADN/metabolismo , Leucemia Megacarioblástica Aguda/metabolismo , Proteínas de Fusión Oncogénica/metabolismo , Proteínas de Unión al ARN/metabolismo , Elementos de Respuesta , Transcripción Genética , Transporte Activo de Núcleo Celular/genética , Línea Celular Tumoral , Núcleo Celular/genética , Proteínas de Unión al ADN/genética , Histona Desacetilasas/genética , Histona Desacetilasas/metabolismo , Humanos , Leucemia Megacarioblástica Aguda/genética , Megacariocitos/metabolismo , Proteínas de Fusión Oncogénica/genética , Estructura Terciaria de Proteína/genética , Proteínas de Unión al ARN/genética , Elementos de Respuesta/genética , Transactivadores , Transcripción Genética/genética , Regulación hacia Arriba/genética , Factor de Transcripción YY1/genética , Factor de Transcripción YY1/metabolismo
3.
Oncogene ; 24(33): 5191-7, 2005 Aug 04.
Artículo en Inglés | MEDLINE | ID: mdl-15897884

RESUMEN

We analysed a complex translocation involving chromosomes 7, 11, 19 and 22 in infant acute monocytic leukemia, and identified that the MLL gene on 11q23 was fused to the unconventional myosin type 1F, MYO1F, gene on 19p13.2-13.3. MYO1F consists of at least 28 exons and was predicted to encode a 1098-amino-acid with an N-terminal head domain containing both ATP-binding and actin-binding sequences, a neck domain with a single IQ motif, and a tail with TH1, TH2 and SH3 domains. Northern blot analysis of RNAs prepared from multiple tissues showed that the expression of approximately 4-kb transcripts appeared constant in most tissues examined. However, MYO1F was expressed in only three of 22 leukemic cell lines. The MLL-MYO1F fusion protein contains almost the entire MYO1F, however, C-terminal MYO1F has neither the transactivation domain nor the dimerization domain found in various MLL fusion partners. Further analysis of this novel type of MLL fusion protein would provide new insights into leukemogenesis. MYO1F is the fourth partner gene of MLL on 19p13. At the cytogenetic level, it may be difficult to distinguish MLL-ENL, MLL-ELL, MLL-EEN and MLL-MYO1F fusions created by t(11;19)(q23;p13), and it is likely that cases of t(11;19) lacking a known fusion gene may result in this gene fusion.


Asunto(s)
Proteínas de Unión al ADN/genética , Leucemia Monocítica Aguda/genética , Miosina Tipo I/genética , Proto-Oncogenes/genética , Factores de Transcripción/genética , Translocación Genética , Secuencia de Aminoácidos , Secuencia de Bases , Línea Celular Tumoral , Cromosomas Humanos Par 11 , Cromosomas Humanos Par 19 , Cromosomas Humanos Par 22 , Cromosomas Humanos Par 7 , Femenino , Reordenamiento Génico , N-Metiltransferasa de Histona-Lisina , Humanos , Lactante , Datos de Secuencia Molecular , Proteína de la Leucemia Mieloide-Linfoide
4.
Cancer Res ; 62(14): 4075-80, 2002 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-12124344

RESUMEN

There are a limited number of reports of acute myeloid leukemia (AML) with t(10;11)(q22;q23). We showed that the MLL gene on 11q23 was fused to the LCX (leukemia-associated protein with a CXXC domain) gene on 10q22 in a de novoadult AML-M2 with trilineage dysplasia having t(10;11)(q22;q23). LCX consisted of at least 12 exons and was predicted to encode a 2136-amino-acid protein with an estimated molecular mass of 235.3 kDa. The LCX protein had a zinc-binding CXXC domain that MLL also contains within a methyltransferase domain, three nuclear localization signals, an alpha-helical coiled-coil region, and two homologous regions to CG2083 proteins of Drosophila melanogaster. We found approximately 12-, 9.5-, and 7.5-kb transcripts of LCX. Expression of the 7.5-kb transcript was detected in fetal heart, lung, and brain, and in adult skeletal muscle, thymus, and ovary. Expression of the 9.5-kb transcript was detected in fetal lung and brain and in adult ovary. Expression of the 12-kb transcript was detected in fetal heart and brain and in adult thymus and ovary. LCX was expressed in 8 of 22 leukemic cell lines, but not in EBV-induced normal B-cell lines. The MLL-LCX fusion protein lacked a CXXC domain of LCX, but retained an alpha-helical coiled-coil region at the COOH terminus, similar to MLL-SEPTING, MLL-CDCREL1, MLL-AF1p/Eps15, and MLL-AF6, which suggests that these fusion proteins are involved in the pathogenesis of 11q23-associated leukemia through similar mechanisms.


Asunto(s)
Cromosomas Humanos Par 10 , Cromosomas Humanos Par 11 , Proteínas de Unión al ADN/genética , Leucemia Mieloide Aguda/genética , Proteínas de Fusión Oncogénica/genética , Proto-Oncogenes , Factores de Transcripción , Translocación Genética , Anciano , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Rotura Cromosómica , Clonación Molecular , ADN Complementario/genética , ADN de Neoplasias/genética , Drosophila melanogaster/genética , N-Metiltransferasa de Histona-Lisina , Humanos , Leucemia Mieloide Aguda/patología , Masculino , Oxigenasas de Función Mixta , Datos de Secuencia Molecular , Proteína de la Leucemia Mieloide-Linfoide , Estructura Terciaria de Proteína , Proteínas Proto-Oncogénicas , Homología de Secuencia de Aminoácido
5.
Cancer Res ; 62(2): 333-7, 2002 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-11809673

RESUMEN

t(X;11) is a recurrent translocation in pediatric acute myeloid leukemia (AML). We showed that the MLL gene on 11q23 was fused to the SEPTIN6 gene on Xq24, a human homologue to mouse Septin6, in three de novo infant AML with complex chromosomal abnormalities involving 11q23 and Xq22-24. SEPTIN6 consisted of at least 12 exons and was predicted to encode at least two types of proteins by alternative splicing. Expression of approximately 2.3-, 3.1-, and 4.6-kb SEPTIN6 transcripts was simultaneously detected in fetal lung, liver, and brain, in all of the adult tissues except brain, and in acute lymphoblastic leukemia and AML cell lines. However, the expression of an approximately 2.7-kb transcript was detected alone in fetal heart and adult brain. The SEPTIN6 protein is homologous to septin family members including CDCREL1 and AF17q25/MSF, which generate fusion products with MLL. The MLL-SEPTIN6 fusion proteins contain almost the entire septin protein, similar to MLL-CDCREL1 and MLL-AF17q25/MSF. Notably, all three of the patients were diagnosed with M1 or M2. Combined present results and literatures suggest that AML with the MLL-SEPTIN6 fusion gene is a subset of infant AML, which differentiate into the myeloid lineage, although AML with other MLL fusion genes is capable of differentiating into the myelomonocytic or monocytic lineage.


Asunto(s)
Cromosomas Humanos Par 11 , Proteínas de Unión al ADN/genética , Proteínas de Unión al GTP/genética , Leucemia Mieloide Aguda/genética , Proto-Oncogenes , Factores de Transcripción , Translocación Genética , Cromosoma X , Adulto , Animales , Fusión Artificial Génica , Clonación Molecular , Proteínas del Citoesqueleto , ADN Complementario/genética , ADN de Neoplasias/genética , Femenino , Proteínas de Unión al GTP/biosíntesis , Expresión Génica , N-Metiltransferasa de Histona-Lisina , Humanos , Lactante , Leucemia Mieloide Aguda/metabolismo , Masculino , Ratones , Proteína de la Leucemia Mieloide-Linfoide , Septinas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA